Samuel K. Kulp
10Patents
2h-index
13Co-inventors
47Inventor score
Filing activity: Apr 13, 2010 → Dec 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8309768B2 | FTY720-derived anticancer agents | Chemistry; Metallurgy | 5 | Active |
| US9174951B2 | Glucose transporter inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8461362B2 | Protein phosphatase 2A-activating agents | Chemistry; Metallurgy | 1 | Active |
| US8362071B2 | Antiadhesion agents | Human Necessities | 1 | Active |
| US8580827B2 | Anti-Francisella agents | Human Necessities | 0 | Active |
| US8658647B2 | Integrin-linked kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9079899B2 | Anti-staphylococcal celecoxib derivatives | Chemistry; Metallurgy | 0 | Active |
| US11529323B2 | Methods and compositions for the treatment of cancer cachexia | Human Necessities | 0 | Active |
| US11219607B2 | Methods for suppressing cancer-related cachexia | Human Necessities | 0 | Active |
| US11938105B1 | Methods and compositions for the treatment of cancer cachexia | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.